Immune Responses to the Flu Shot During Pregnancy
NCT02148874 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 287
Last updated 2019-09-24
Summary
This study will examine effects of everyday life stress and obesity on immune responses to influenza virus vaccine (the flu shot) during pregnancy. Following vaccination, antibody levels against influenza (the flu) increase. Higher antibody levels indicate better immune protection from influenza. In addition to providing protection from the flu for yourself, being vaccinated during pregnancy may protect your baby from the flu during the first six months of life during which time infants cannot be vaccinated. Our primary goals are to determine whether greater life stress and obesity reduce 1) antibody responses to the flu shot in women and 2) antibody levels in the newborn at the time of delivery.
Conditions
- Pregnancy
Interventions
- BIOLOGICAL
-
influenza virus vaccination
comparison of immune responses to the flu vaccine in obese and non-obese populations
Sponsors & Collaborators
-
Lisa Christian
lead OTHER
Principal Investigators
-
Lisa M. Christian, PhD · Ohio State University
Eligibility
- Min Age
- 18 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2017-05-31
- Completion
- 2019-08-31
Countries
- United States
Study Locations
More Related Trials
-
"COhort Study on A/H1N1 FLU During PREGnancy"
NCT01192737 ·Status: COMPLETED
-
Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy
NCT04962477 ·Status: COMPLETED
-
Pregnant Women Vaccinated Against Covid-19.
NCT04957953 ·Status: COMPLETED
-
Promotion of RSV Immunization Through Multiple Efforts
NCT06640868 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 and Obstetric Transmission
NCT04418557 ·Status: COMPLETED
-
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
NCT01412801 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age
NCT01193920 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020
NCT04723771 ·Status: COMPLETED
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
Preparing for Maternal GBS Vaccine Trials in Africa
NCT06833957 ·Status: RECRUITING
-
Increasing Influenza and Tdap Vaccination of Pregnant Women
NCT04444518 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
NCT04568044 ·Status: ACTIVE_NOT_RECRUITING
-
Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
NCT04152278 ·Status: COMPLETED
-
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
NCT00532324 ·Status: COMPLETED ·Phase: NA
-
Assessment of Alterations in Immune Function During Pregnancy and Post Parturition
NCT01200979 ·Status: COMPLETED
-
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811 ·Status: COMPLETED ·Phase: NA
-
Characteristics of COVID-19 Infection Among PREGnant Women
NCT04398264 ·Status: COMPLETED
-
Evaluation of the IND One Step Strep A Rapid Test vs. Culture
NCT01491776 ·Status: UNKNOWN
-
Pregnancy, Arsenic and Immune Response
NCT03930017 ·Status: COMPLETED
-
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468 ·Status: COMPLETED
-
COVID Booster in Pregnancy and Lactation
NCT05543993 ·Status: COMPLETED
-
Maternal Determinants of Immunity to Influenza
NCT06716567 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo
NCT06849037 ·Status: RECRUITING ·Phase: NA
-
Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women
NCT00343317 ·Status: COMPLETED ·Phase: NA
-
Association Between a Mother's Exposure to "Strep Throat" and Her Baby's Developing Heart Disease
NCT01603732 ·Status: COMPLETED